All 160 LABU (DIREXION DAILY S&P BIOTECH BULL 3X SHARES DIREXION DAILY S&P BIOTECH BULL 3X SHARES) Holdings
There are 160 LABU holdings. Top 10 companies weight: 101.48%.
Total Market Cap: $1.71T
Rank | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Average | (160 stocks) | +9.98% | 31.31 | 16.61 | 0.44 | +19.94% | +14.35% | 0.66 | ||||||||||
1 | n/a | N/A | 38.69% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
2 | n/a | Dreyfus Govt Cash Man Ins | 30.11% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
3 | n/a | Goldman Finl Sq Trsry Inst 506 | 18.72% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
4 | n/a | Goldman Sachs Fin Gov 465 Institut | 6.47% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
5 | n/a | Dreyfus Trsry Securities Cash Mgmt | 4.28% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
6 | APGE | Apogee Therapeutics Inc | 0.70% | $134.20 | $10B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.00% | N/A |
7 | KYMR | Kymera Therapeutics Inc Ordinary Shares | 0.66% | $113.37 | $9.38B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 79 | +10.38% | $125 | +14.59% | 1.53 |
8 | MRNA | Moderna Inc | 0.64% | $59.66 | $27B | Biotechnology | Healthcare | N/A | N/A | 23.04 | N/A | N/A | N/A | 46 | -18.84% | $48 | -28.69% | 1.37 |
9 | VKTX | Viking Therapeutics Inc | 0.61% | $37.95 | $4.38B | Biotechnology | Healthcare | +47.58% | N/A | N/A | N/A | N/A | N/A | 78 | +143.95% | $93 | +45.25% | 1.53 |
10 | ERAS | Erasca Inc | 0.60% | $19.38 | $5.51B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +17.65% | $23 | -0.63% | 1.38 |
11 | ORKA | Oruka Therapeutics Inc | 0.59% | $94.32 | $4.35B | Biotechnology | Healthcare | +11.91% | N/A | N/A | N/A | N/A | N/A | 78 | +53.38% | $145 | +32.89% | N/A |
12 | PRAX | N/A | 0.59% | $317.87 | $8.87B | Biotechnology | Healthcare | -18.18% | N/A | N/A | N/A | N/A | N/A | 75 | +91.92% | $610 | +4.14% | 0.93 |
13 | CGON | Cg Oncology Inc | 0.59% | $71.72 | $6.42B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 79 | +25.89% | $90 | 0.00% | 1.46 |
14 | TWST | Twist Bioscience Corp | 0.58% | $95.86 | $5.76B | Diagnostics & Research | Healthcare | -10.29% | N/A | N/A | N/A | N/A | N/A | 77 | -7.68% | $89 | -4.63% | 2.04 |
15 | SYRE | Spyre Therapeutics Inc | 0.57% | $102.70 | $8.05B | Biotechnology | Healthcare | -2.15% | N/A | N/A | N/A | N/A | N/A | 75 | +1.20% | $104 | -9.05% | 1.75 |
16 | MIRM | Mirum Pharmaceuticals Inc | 0.56% | $117.05 | $7.37B | Biotechnology | Healthcare | -34.51% | N/A | 2000.00 | N/A | N/A | N/A | 82 | +25.16% | $147 | +49.35% | 0.84 |
17 | SRRK | Scholar Rock Holding Corp | 0.56% | $50.88 | $6.44B | Biotechnology | Healthcare | +5.29% | N/A | N/A | N/A | N/A | N/A | 79 | +16.57% | $59 | +9.01% | 0.67 |
18 | RVMD | Revolution Medicines Inc Ordinary Shares | 0.56% | $183.29 | $37B | Biotechnology | Healthcare | +30.12% | N/A | N/A | N/A | N/A | N/A | 78 | +9.41% | $201 | +44.92% | 1.09 |
19 | PCVX | Vaxcyte Inc Ordinary Shares | 0.56% | $58.04 | $8.19B | Biotechnology | Healthcare | +33.90% | N/A | N/A | N/A | N/A | N/A | 75 | +87.80% | $109 | +20.85% | 0.73 |
20 | BBIO | Bridgebio Pharma Inc | 0.55% | $82.45 | $16B | Biotechnology | Healthcare | -3.14% | N/A | N/A | N/A | N/A | N/A | 79 | +27.67% | $105 | +5.99% | 1.03 |
21 | INSM | Insmed Inc | 0.55% | $108.62 | $24B | Biotechnology | Healthcare | +12.24% | N/A | 16.37 | 1.09 | N/A | N/A | 80 | +80.80% | $196 | +34.13% | 0.77 |
22 | DNTH | Dianthus Therapeutics Inc | 0.55% | $105.72 | $5.45B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +21.62% | $129 | 0.00% | 1.12 |
23 | RYTM | Rhythm Pharmaceuticals Inc | 0.55% | $106.60 | $7.51B | Biotechnology | Healthcare | +17.00% | N/A | N/A | N/A | N/A | N/A | 79 | +31.08% | $140 | +40.62% | 0.88 |
24 | RLAY | Relay Therapeutics Inc Ordinary Shares | 0.55% | $19.30 | $3.69B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 79 | +31.50% | $25 | -10.84% | 1.84 |
25 | CYTK | Cytokinetics Inc | 0.55% | $81.11 | $10B | Biotechnology | Healthcare | +27.73% | N/A | 117.65 | N/A | N/A | N/A | 80 | +32.91% | $108 | +21.93% | 0.77 |
26 | ROIV | Roivant Sciences Ltd Ordinary Shares | 0.55% | $34.96 | $25B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 76 | +12.47% | $39 | 0.00% | 0.90 |
27 | NTRA | Natera Inc | 0.54% | $267.18 | $40B | Diagnostics & Research | Healthcare | -11.74% | N/A | N/A | N/A | N/A | N/A | 77 | +5.60% | $282 | +17.99% | 1.29 |
28 | COGT | Cogent Biosciences Inc | 0.54% | $39.64 | $6.71B | Biotechnology | Healthcare | -15.32% | N/A | N/A | N/A | N/A | N/A | 75 | +36.86% | $54 | +42.82% | 1.71 |
29 | RARE | Ultragenyx Pharmaceutical Inc | 0.54% | $28.62 | $3.12B | Biotechnology | Healthcare | +15.22% | N/A | N/A | N/A | N/A | N/A | 78 | +83.54% | $53 | -19.29% | 0.97 |
30 | PTGX | Protagonist Therapeutics Inc | 0.54% | $138.31 | $8.70B | Biotechnology | Healthcare | +1.43% | N/A | 28.41 | N/A | N/A | N/A | 78 | -9.51% | $125 | +24.19% | 0.22 |
31 | TGTX | Tg Therapeutics Inc | 0.53% | $53.95 | $8.64B | Biotechnology | Healthcare | N/A | 18.97 | 58.48 | 0.02 | N/A | N/A | 66 | +8.21% | $58 | +7.22% | 0.80 |
32 | TVTX | Travere Therapeutics Inc Ordinary Shares | 0.53% | $56.58 | $5.24B | Biotechnology | Healthcare | -44.12% | N/A | 77.52 | N/A | N/A | N/A | 76 | +3.15% | $58 | +34.24% | 1.28 |
33 | CELC | Celcuity Inc | 0.53% | $91.69 | $4.42B | Biotechnology | Healthcare | +36.83% | N/A | N/A | N/A | N/A | N/A | 79 | +78.26% | $163 | +33.98% | 1.07 |
34 | ALKS | Alkermes Plc | 0.51% | $52.85 | $8.65B | Drug Manufacturers - Specialty & Generic | Healthcare | N/A | 56.04 | 136.99 | 1.96 | N/A | N/A | N/A | N/A | N/A | +16.96% | N/A |
35 | KRYS | Krystal Biotech Inc | 0.51% | $339.06 | $10B | Biotechnology | Healthcare | N/A | 45.34 | 44.84 | 0.57 | N/A | N/A | 72 | +6.67% | $362 | +40.35% | 0.92 |
36 | SMMT | Summit Therapeutics Inc Ordinary Shares | 0.50% | $14.63 | $12B | Biotechnology | Healthcare | N/A | N/A | 3.72 | N/A | N/A | N/A | 60 | +96.24% | $29 | +13.03% | 1.76 |
37 | PTCT | Ptc Therapeutics Inc | 0.50% | $78.50 | $6.53B | Biotechnology | Healthcare | -16.59% | N/A | 56.50 | 0.81 | N/A | N/A | 75 | +22.20% | $96 | +13.28% | 0.99 |
38 | MDGL | Madrigal Pharmaceuticals Inc | 0.49% | $546.79 | $13B | Biotechnology | Healthcare | +23.26% | N/A | 666.67 | N/A | N/A | N/A | 76 | +24.15% | $679 | +43.16% | 0.76 |
39 | VERA | Vera Therapeutics Inc Class A | 0.49% | $37.17 | $3.04B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +120.04% | $82 | +17.52% | 1.22 |
40 | REGN | Regeneron Pharmaceuticals Inc | 0.48% | $675.19 | $69B | Biotechnology | Healthcare | +20.31% | 15.86 | 15.08 | 88.04 | N/A | N/A | 72 | +21.33% | $819 | +3.01% | 0.60 |
41 | VRTX | Vertex Pharmaceuticals Inc | 0.48% | $482 | $121B | Biotechnology | Healthcare | +9.89% | 27.99 | 25.45 | 1.72 | N/A | N/A | 72 | +15.03% | $554 | +19.72% | 0.49 |
42 | INCY | Incyte Corp | 0.48% | $117.39 | $23B | Biotechnology | Healthcare | +27.16% | 15.82 | 15.06 | N/A | N/A | N/A | 61 | -3.04% | $114 | +8.35% | 0.57 |
43 | NBIX | Neurocrine Biosciences Inc | 0.48% | $179.05 | $17B | Drug Manufacturers - Specialty & Generic | Healthcare | +9.25% | 25.72 | 24.10 | 0.21 | N/A | N/A | 75 | +11.83% | $200 | +12.78% | 0.79 |
44 | BEAM | Beam Therapeutics Inc | 0.48% | $27.29 | $3.17B | Biotechnology | Healthcare | -36.45% | N/A | N/A | N/A | N/A | N/A | 73 | +91.68% | $52 | -22.11% | 1.82 |
45 | ABBV | Abbvie Inc | 0.48% | $256.18 | $432B | Drug Manufacturers - General | Healthcare | -19.65% | 139.08 | 18.02 | 0.40 | N/A | N/A | 74 | +4.06% | $267 | +21.25% | 0.28 |
46 | SLS | Sellas Life Sciences Group Inc | 0.48% | $12.90 | $2.32B | Biotechnology | Healthcare | -32.56% | N/A | N/A | N/A | N/A | N/A | 87 | +113.18% | $28 | +7.49% | 0.91 |
47 | CRSP | Crispr Therapeutics Ag | 0.47% | $48.15 | $4.95B | Biotechnology | Healthcare | +2.10% | N/A | 23.36 | N/A | N/A | N/A | 70 | +79.04% | $86 | -17.34% | 1.44 |
48 | HALO | Halozyme Therapeutics Inc | 0.47% | $78.60 | $8.99B | Biotechnology | Healthcare | +20.06% | 25.62 | 10.78 | N/A | N/A | N/A | 67 | +6.74% | $84 | +13.10% | 0.62 |
49 | ARWR | Arrowhead Pharmaceuticals Inc | 0.47% | $74.52 | $10B | Biotechnology | Healthcare | +15.23% | N/A | 111.11 | N/A | N/A | N/A | 78 | +28.82% | $96 | +1.87% | 1.64 |
50 | AMGN | Amgen Inc | 0.47% | $366.24 | $193B | Drug Manufacturers - General | Healthcare | +3.49% | 24.75 | 16.47 | 0.79 | N/A | N/A | 60 | -2.63% | $357 | +11.87% | 0.46 |
LABU (DIREXION DAILY S&P BIOTECH BULL 3X SHARES DIREXION DAILY S&P BIOTECH BULL 3X SHARES) Sector Allocation
HEALTHCARE
44.70%INFORMATION TECHNOLOGY
0.00%COMMUNICATION SERVICES
0.00%CONSUMER DISCRETIONARY
0.00%CONSUMER STAPLES
0.00%INDUSTRIALS
0.00%MATERIALS
0.00%UTILITIES
0.00%ENERGY
0.00%FINANCIALS
0.00%REAL ESTATE
0.00%